PHASE-II STUDY OF LOW-DOSE CONTINUOUS INFUSION HOMOHARRINGTONINE IN REFRACTORY ACUTE MYELOGENOUS LEUKEMIA

被引：0
|
作者：
KANTARJIAN, HM
KEATING, MJ
WALTERS, RS
KOLLER, CA
MCCREDIE, KB
FREIREICH, EJ
机构：
来源：
CANCER | 1989年 / 63卷 / 05期
关键词：
D O I：
10.1002/1097-0142(19890301)63:5<813::AID-CNCR2820630502>3.0.CO;2-V
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：813 / 817
页数：5
相关论文
共 50 条
  • [11] Phase II study of low-dose decitabine in patients with chronic myelogenous leukemia resistant to imatinib mesylate
    Issa, JPJ
    Gharibyan, V
    Cortes, J
    Jelinek, J
    Morris, G
    Verstovsek, S
    Talpaz, M
    Garcia-Manero, G
    Kantarjian, HM
    JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (17) : 3948 - 3956
  • [12] CONTINUOUS INFUSION HOMOHARRINGTONINE (NSC-141633) IN REFRACTORY ACUTE NONLYMPHOCYTIC LEUKEMIA - AN ECOG PILOT-STUDY
    STEWART, JA
    CASSILETH, PA
    BENNETT, JM
    OCONNELL, MJ
    AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS, 1988, 11 (06): : 627 - 629
  • [13] LOW-DOSE CONTINUOUS INFUSION 5-FLUOROURACIL AND CISPLATIN - PHASE-II EVALUATION IN ADVANCED COLORECTAL-CARCINOMA
    LORUSSO, P
    PAZDUR, R
    REDMAN, BG
    KINZIE, J
    VAITKEVICIUS, V
    AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS, 1989, 12 (06): : 486 - 490
  • [14] AMSA - A PHASE-II TRIAL IN RESISTANT AND RECURRENT ACUTE MYELOGENOUS LEUKEMIA
    BOCCIA, R
    ZIGHELBOIM, J
    CHAMPLIN, RE
    CHUN, CK
    GALE, RP
    MEDICAL AND PEDIATRIC ONCOLOGY, 1984, 12 (03): : 178 - 179
  • [15] PHASE-II TRIAL OF VINCRISTINE INFUSION IN ACUTE-LEUKEMIA
    JACKSON, DV
    CHAUVENET, AR
    CALLAHAN, RD
    ATKINS, JN
    TRAHEY, TF
    SPURR, CL
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 1985, 14 (01) : 26 - 29
  • [16] CONTINUOUS INTRAVENOUS-INFUSION OF HIGH-DOSE RECOMBINANT INTERLEUKIN-2 FOR ACUTE MYELOID-LEUKEMIA - A PHASE-II STUDY
    LIM, SH
    NEWLAND, AC
    KELSEY, S
    BELL, A
    OFFERMAN, E
    RIST, C
    GOZZARD, D
    BAREFORD, D
    SMITH, MP
    GOLDSTONE, AH
    CANCER IMMUNOLOGY IMMUNOTHERAPY, 1992, 34 (05) : 337 - 342
  • [17] PHASE-II STUDY OF AMSACRINE GLUCONATE IN REFRACTORY LEUKEMIA
    OMURA, GA
    WINTON, EF
    VOGLER, WR
    ZUCKERMAN, KS
    GRILLOLOPEZ, AJ
    CANCER TREATMENT REPORTS, 1983, 67 (12): : 1131 - 1132
  • [18] PHASE-II TRIAL OF MITOXANTRONE IN REFRACTORY ACUTE-LEUKEMIA
    ESTEY, EH
    KEATING, MJ
    MCCREDIE, KB
    BODEY, GP
    FREIREICH, EJ
    CANCER TREATMENT REPORTS, 1983, 67 (04): : 389 - 390
  • [19] PHASE-II TRIAL OF LOW-DOSE 2-DEOXYCOFORMYCIN IN REFRACTORY MALIGNANT-LYMPHOMAS
    CUMMINGS, FJ
    TSIATIS, A
    OCONNELL, M
    CREECH, R
    PROCEEDINGS OF THE AMERICAN ASSOCIATION FOR CANCER RESEARCH, 1986, 27 : 197 - 197
  • [20] Continuous infusion intermediate-dose cytarabine, mitoxantrone, plus etoposide for refractory or early relapsed acute myelogenous leukemia
    Lee, JH
    Choi, SJ
    Lee, JH
    Lee, YS
    Seol, M
    Ryu, SG
    Jang, S
    Park, CJ
    Chi, HS
    Lee, JS
    Kim, WK
    Lee, KH
    LEUKEMIA RESEARCH, 2006, 30 (02) : 204 - 210
12345